Tag: Lymphoma Diagnosis and Treatment
Tucidinostat plus R-CHOP improved event-free survival in DEL
—
What the study found The study found that adding tucidinostat, an oral histone deacetylase inhibitor, to R-CHOP improved outcomes for people with newly diagnosed MYC/BCL2 double-expressor lymphoma, a type of diffuse large B-cell lymphoma marked by coexpression of the MYC and BCL2 proteins. The combination was associated with better event-free survival and a higher complete…